
Warner Chilcott
ClosedSpecialty pharmaceuticals for women's health and beyond
Rockaway, United States · Founded 1968 · $3.0B raised
- Headquarters
- Rockaway, New Jersey
- Employees
- 1001–5000
- Founded
- 1968
- Business Model
- B2B
- Website
- wcrx.com
- Total Funding
- $3.0B
- Last Round
- $3.0B Private EquityJan 2004
- Rounds
- 1
About
Warner Chilcott was a leading specialty pharmaceutical company focused on women's healthcare, gastroenterology, urology, and dermatology branded prescription drugs, primarily marketed in the United States. The company developed, manufactured, and sold products in these therapeutic areas before being acquired by Actavis in 2013 for approximately $8.5 billion.
Summary
Warner Chilcott is a Biotech company based in Rockaway, United States, founded in 1968. It has raised $3.0B in total across 1 round, most recently a $3.0B Private Equity round in Jan 2004. Investors include Bain Capital, J.P. Morgan and DLJ Capital Group.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2013
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Novotech is a full-service CRO with integrated labs providing clinical drug development services ...

